Response to Comment on: Greenbaum et al. Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes. Diabetes 2012;61:1323–1330

Ejemplares similares

• Comment on: Greenbaum et al. Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes. Diabetes 2012;61:1323–1330
  por: Vialettes, Bernard, et al.
  Publicado: (2012)
• Response to Comment on: Greenbaum et al. Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data. Diabetes 2012;61:2066–2073
  por: Greenbaum, Carla J., et al.
  Publicado: (2013)
• Comment on: Greenbaum et al. Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data. Diabetes 2012;61:2066–2073
  por: Rios, Paola, et al.
  Publicado: (2013)
• Comment on: Marquez et al. Low-Frequency Variants in HMGA1 Are Not Associated With Type 2 Diabetes Risk. Diabetes 2012;61:524–530
  por: Brunetti, Antonio, et al.
  Publicado: (2012)
• Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes
  por: Greenbaum, Carla J., et al.
  Publicado: (2012)